rotigotine sustained-release / Auritec Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rotigotine sustained-release / Auritec Pharma
ChiCTR1900027183: Evaluation of the efficacy and safety of injection of rotigotine sustained-release microspheres in the treatment of patients with early-stage primary Parkinson's disease: a multicenter, randomized, double-blind, placebo-controlled study

Not yet recruiting
3
294
 
LY03003 ;placebo
Xuanwu Hospital Capital Medical University; Shandong Luye Pharmaceutical Co., Ltd, Sponsor Supplied
Early primary Parkinson's disease
 
 

Download Options